BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24576948)

  • 21. Comparison of the in-house made Carba-NP and Blue-Carba tests: Considerations for better detection of carbapenemase-producing Enterobacteriaceae.
    Pires J; Tinguely R; Thomas B; Luzzaro F; Endimiani A
    J Microbiol Methods; 2016 Mar; 122():33-7. PubMed ID: 26773493
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The management of multidrug-resistant Enterobacteriaceae.
    Bassetti M; Peghin M; Pecori D
    Curr Opin Infect Dis; 2016 Dec; 29(6):583-594. PubMed ID: 27584587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenemase-producing Enterobacteriaceae.
    Doi Y; Paterson DL
    Semin Respir Crit Care Med; 2015 Feb; 36(1):74-84. PubMed ID: 25643272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening suspected cases for carbapenemase-producing Enterobacteriaceae, inclusion criteria and demand.
    Venanzio V; Gharbi M; Moore LS; Robotham J; Davies F; Brannigan E; Galletly T; Holmes AH
    J Infect; 2015 Oct; 71(4):493-5. PubMed ID: 26070742
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical laboratory detection of carbapenem-resistant and carbapenemase-producing Enterobacteriaceae.
    Miller S; Humphries RM
    Expert Rev Anti Infect Ther; 2016 Aug; 14(8):705-17. PubMed ID: 27348447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Future alternatives for the treatment of infections caused by carbapenemase-producing Enterobacteriaceae: what is in the pipeline?
    Horcajada JP; Torre-Cisneros J; Peña C; Fariñas MC
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():56-60. PubMed ID: 25542053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter.
    Livermore DM; Woodford N
    Trends Microbiol; 2006 Sep; 14(9):413-20. PubMed ID: 16876996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel.
    Baraniak A; Izdebski R; Fiett J; Herda M; Derde LP; Bonten MJ; Adler A; Carmeli Y; Goossens H; Hryniewicz W; Brun-Buisson C; Gniadkowski M;
    Antimicrob Agents Chemother; 2015 Dec; 60(3):1912-7. PubMed ID: 26711772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The real threat of Klebsiella pneumoniae carbapenemase-producing bacteria.
    Nordmann P; Cuzon G; Naas T
    Lancet Infect Dis; 2009 Apr; 9(4):228-36. PubMed ID: 19324295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Simplified protocol for Carba NP test for enhanced detection of carbapenemase producers directly from bacterial cultures].
    Sakurada A
    Rev Chilena Infectol; 2016 Feb; 33(1):95. PubMed ID: 26965887
    [No Abstract]   [Full Text] [Related]  

  • 32. ESBL- and Carbapenemase-Producing Enterobacteriaceae in Patients with Bacteremia, Yangon, Myanmar, 2014.
    Myat TO; Hannaway RF; Zin KN; Htike WW; Win KK; Crump JA; Murdoch DR; Ussher JE
    Emerg Infect Dis; 2017 May; 23(5):857-859. PubMed ID: 28418298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of blaVIM-2 carbapenemase in Pseudomonas aeruginosa in Ireland.
    Walsh F; Rogers TR
    J Antimicrob Chemother; 2008 Jan; 61(1):219-20. PubMed ID: 18024489
    [No Abstract]   [Full Text] [Related]  

  • 34. Evolution of carbapenemase-producing Enterobacteriaceae at the global and national level: what should be expected in the future?
    Oteo J; Miró E; Pérez-Vázquez M; Navarro F
    Enferm Infecc Microbiol Clin; 2014 Dec; 32 Suppl 4():17-23. PubMed ID: 25542048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rates of faecal colonization by carbapenemase-producing Enterobacteriaceae among patients admitted to ICUs in Spain.
    Oteo J; Alcaraz R; Bou G; Conejo C; Díaz-Lamas AM; Fernández-Martínez M; Fontanals D; González-López JJ; López-Contreras J; Martínez-Martínez L; Mora-Rillo M; Muñoz M; Navarro F; Oliver A; Pintado V; Ruiz-Carrascoso G; Ruiz-Garbajosa P; Sánchez-Porto A; Sánchez-Romero I; Zamorano L; Aracil B; Rodríguez-Baño J; ;
    J Antimicrob Chemother; 2015 Oct; 70(10):2916-8. PubMed ID: 26163400
    [No Abstract]   [Full Text] [Related]  

  • 36. Current status of carbapenemases in Latin America.
    Maya JJ; Ruiz SJ; Blanco VM; Gotuzzo E; Guzman-Blanco M; Labarca J; Salles M; Quinn JP; Villegas MV
    Expert Rev Anti Infect Ther; 2013 Jul; 11(7):657-67. PubMed ID: 23879607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds.
    Pournaras S; Poulou A; Tsakris A
    J Antimicrob Chemother; 2010 Jul; 65(7):1319-21. PubMed ID: 20395214
    [TBL] [Abstract][Full Text] [Related]  

  • 38. First Report of Klebsiella pneumoniae-Carbapenemase-3-Producing Escherichia coli ST479 in Poland.
    Ojdana D; Sacha P; Olszańska D; Majewski P; Wieczorek P; Jaworowska J; Sieńko A; Jurczak A; Tryniszewska E
    Biomed Res Int; 2015; 2015():256028. PubMed ID: 26339599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of different pretreatment protocols to detect accurately clinical carbapenemase-producing Enterobacteriaceae by MALDI-TOF.
    Monteferrante CG; Sultan S; Ten Kate MT; Dekker LJ; Sparbier K; Peer M; Kostzrewa M; Luider TM; Goessens WH; Burgers PC
    J Antimicrob Chemother; 2016 Oct; 71(10):2856-67. PubMed ID: 27287232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New carbapenases in Brazil.
    Carneiro M; Gonçalves RA; de Souza JG; Teixeira CB; Krummenauer EC; Machado JA; Waib LF; Pina Trench FJ
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):155-6. PubMed ID: 24325641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.